Demonstrating Efficacy in Clinical Trials with Novel & Meaningful Endpoints
Time: 11:00 am
day: Day One Clinical Track AM
Details:
- Exploring why the HiSCR score is not the most clinically meaningful endpoint in HS
- Investigating variance across trials and examine the reproducibility of endpoints
- Identifying the opportunities associated with using innovative endpoints to evaluate the effectiveness of new dermatological treatments
